Literature DB >> 2651333

Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK.

T Toge1, Y Yamaguchi, Y Kegoya, N Baba, E Yanagawa, T Hattori.   

Abstract

The ability of protein-bound polysaccharide (PSK) to block the suppressive activity of soluble suppressor factor (SSF) was investigated. The suppressive activity of SSF derived from U-937 cells on phytohemagglutinin (PHA)-induced lymphocyte proliferative (LP) response was significantly reduced in the presence of PSK. The release of SSF was not inhibited by the treatment of U-937 cells with PSK. The suppressive activity of SSF on LP response to PHA was significantly decreased by the pretreatment of responder lymphocytes with PSK. Studies to determine lymphocyte receptor activity were performed. PSK competed with wheat germ agglutinin (WGA) which recognized the same receptor as SSF on the surface of the lymphocyte. Neither PSK nor serum competed with anti-CD4 monoclonal antibody. Thus, PSK may inhibit SSF-mediated suppression by competing for specific binding sites on the surface of responder lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651333     DOI: 10.1016/0192-0561(89)90093-3

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  5 in total

1.  The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.

Authors:  Y Yamaguchi; T Toge; N Baba; H Kuninobu; Y Kegoya; T Takayama; T Hattori
Journal:  Jpn J Surg       Date:  1990-01

2.  The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.

Authors:  T Toge; Y Yamaguchi; A Sawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.

Authors:  J Sakamoto; A Koike; S Saji; S Teramukai; Y Ohashi; H Nakazato
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

4.  In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.

Authors:  Y Nio; T Shiraishi; M Tsubono; H Morimoto; C C Tseng; S Imai; T Tobe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.

Authors:  Y Maehara; S Inutsuka; H Takeuchi; H Baba; H Kusumoto; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.